The effect on the content of melanocyte-stimulating hormone (MSH) Extracts of stalk-median eminence or posterior lobe from animals with lesions in the paraventricular nuclei, failed to show MSH-releasing factor as it is found in intact animals, nor did they contain MSH-release-inhibiting factor.
INTRODUCTION
It is a generally accepted fact that in amphibians the central nervous system exerts an inhibitory action on the release of intermediate lobe hormone. Experiments in which the connexions between the pituitary and the hypothalamus were inter¬ rupted by section of the stalk (Etkin, 1962) or transplantation of the gland (Etkin, 1941 (Etkin, , 1943 were followed by darkening of the skin as if the secretion of melanocytestimulating hormone (MSH) was increased. Lesions of the hypothalamus produced the same effect (Voitkevich, 1962; Kastin & Ross, 1965) . Furthermore, it has been shown (Taleisnik & Tomatis, 1967 a) that toad hypothalamic extracts contain an agent which inhibits the release of MSH.
In mammals evidence is accumulating that the central nervous system is important in the regulation of MSH secretion in spite of the ignorance about the physiological role of the hormone in this vertebrate class. In rats, transplantation of the pituitary to the renal capsule resulted in a decrease in its content of MSH (Kastin & Ross, 1964) , and suckling stimuli have been shown to induce an acute drop in the MSH content of the pituitary . It has also been shown that the hypothalamus contains agents which stimulate or inhibit the release of MSH (Taleisnik & Orias, 1965; Taleisnik & Tomatis, 19676) .
Destruction of restricted areas in the hypothalamus is a valuable method for studying the control by the hypothalamus of the release of various pituitary hor¬ mones. In the present study, this technique was applied to obtain further informa¬ tion concerning the influence of the central nervous system on MSH release.
MATERIAL AND METHODS
Adult male rats, weighing 180-200 g., were used. By means of a stereotaxic instrument, electrolytic lesions were placed bilaterally either in the median eminence of the tuber cinereum (ME), in the region of the paraventricular nuclei (PVN) or in other regions of the brain. A direct current of 3 mA for 25 sec. was passed through a nichrome electrode. After the lesions had been made the animals were kept in indivi¬ dual cages and were given free access to food and water. One or 15 days after the operation the animals were killed with ether and the pituitary was removed immedi¬ ately, weighed, suspended in an appropriate volume of distilled water and kept frozen until the MSH content was assayed. In a group of animals with lesions in the PVN, the stalk-median eminence (SME) was removed and suspended in an acid solution to study its content of MSH-releasing factor (MSH-RF). The procedure for preparing these extracts has been described previously (Taleisnik & Orias, 1965) .
Localization and site of the lesions were determined by brain reconstruction from unstained sections serially cut at 30 p.
Assay of MSH. MSH was assayed in vitro using toad skin (Taleisnik & Orias, 1965 (Bliss, 1952 fig. 1 ). The rats with lesions in the median eminence could be separated into two groups according to the extension of the injury. In the first group there was extensive injury extending from the caudal part of the optic chiasma to the hypophysial stalk with complete or almost complete destruction of the arcuate nuclei. In the second group the lesions were smaller and were located more basally and included the ventral wall of the third ventricle and the hypophysial stalk. In both groups the portal vessels were damaged (Plate, fig. 2 ).
Control lesions were made in the region of the mammillary bodies or the nucleus caudatus.
MSH activity of pituitary glands of intact rats Single pituitaries from normal rats were assayed to provide control data and information about the variation in individual glands. In ten animals in which the lesions were placed in the region of the PVN but where these nuclei were only destroyed partially or unilaterally, there was a significant increase in pituitary weight considered both in terms of the whole gland or/100 g. body weight. Related to the control group MSH activity/mg. gland was 66-4 + 7-5% and that of the whole gland was 75-0 + 8-9%. These figures are significantly lower (P < 0-01) than those for intact animals but significantly higher (P < 0-001) than those in animals with complete destruction of the PVN.
In order to discard the possibility that the effects of PVN lesions were due to electrolytic deposits from the nichrome electrodes (Everett & Radford, 1961 ) a group of animals was studied in which the lesions were made with platinum electrodes. Table 1 shows that in four such animals with complete destruction of the PVN, MSH activity was 29-6 +3-1 %/mg. gland and 29-5 +4-2 %/gland of that of the control group. There were no changes in the weight of the pituitaries. The values obtained were not different from those in which the lesions had been made with nichrome electrodes.
Effect of lesions in the median eminence In six animals killed 24 hr. after the lesions in the ME the weight of the hypophyses was not significantly different from that in the control group. However, MSH activity in the pituitary decreased markedly (6-3 + 1-0 %/gland and 6-6+ 0-8 %/mg. gland).
Animals with ME lesions, killed 15 days after the operation, were combined in two groups, one with a small lesion and the other with a large lesion. In spite of the differences in the extent of the lesions no difference in the degree of In order to test whether the lack of activity in the extracts from lesioned rats to deplete pituitary MSH was due to the presence of an MSH-R-IF the capacity of such extracts to inhibit the drop in MSH produced by SME extracts from intact animals was studied. One group of animals was therefore injected with SME extract from intact rats only and two other groups with the same dose of SME extract plus SME or posterior lobe extracts from animals with PVN lesions. No significant difference between the two groups was found (Table 3) . (Taleisnik & Orias 1965; Taleisnik, Orias & de Olmos, 1966; Taleisnik & Tomatis, 1967 a) . We believe that the paraventricular nuclei are concerned with specific neurosecretory agents which regulate the release of MSH. In studying the topographic distribution of MSH-RF in the hypothalamus the maximum activity for this principle was found in the PVN (Taleisnik & Tomatis, 19676) , only separation of both principles would resolve this difficulty.
With regard to the effect of lesions in the ME on the pituitary concentration of MSH a striking difference was observed between the animals killed 1 and 15 days after the operation. In the former the MSH concentration of the pituitary was very low, but in the groups studied 14 days later most of the activity had been restored. These results contrast with the low values of adrenocorticotrophic (Fortier & de Groot, 1959; McCann & Haberland, 1960) and luteinizing hormone (Taleisnik & McCann, 1961) found in the hypophysis after similar lesions in the hypothalamus. This might be taken as evidence that the pituitary gland can manufacture MSH despite disconnexion from the central nervous system. The almost normal pituitary MSH activity/mg. gland in the animals with ME lesions contrasts with the low value reported in glands transplanted under the renal capsule (Kastin & Ross, 1964) . This difference could be due to the release into the systemic circulation of hypothalamic agents acting on the transplanted pituitary. Lesions in the ME would suppress such a mechanism because of the destruction of the areas from which such agents are released.
If it is assumed that more MSH is released from the mammalian pars intermedia after disconnexion from the hypothalamus, as has been shown in amphibians (Etkin, 1941 (Etkin, , 1943 , then the higher pituitary MSH content in the animals killed 15 days after ME lesions (as compared to those killed at 24 hr.), tends to the conclusion that an increase in synthesis also occurs so as to maintain a near normal concentration of MSH despite an increased secretion.
Extracts of the supra-optic nuclei have been shown to possess an agent which inhibits the release of MSH (Taleisnik & Tomatis, 19676) . Since the PVN is rich in MSH-RF, both the paraventricular and supraoptic nuclei may be involved in the control of MSH secretion and exert antagonistic actions. In the light of the present results it will be of interest to examine the effects of lesions of the supraoptic nuclei on the secretion of MSH.
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